Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03934398 · ClinicalTrials.gov registry record
Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 41
- Enrollment target
NCT03934398: Completed study, sponsored by Johns Hopkins University.
NCT03934398 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03934398 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure. The investigators will also investigate for predictors of vascular function and determine if predictors vary by level of sodium intake.
Primary Outcome
This will be determined from Pulse wave velocity (m/sec) done at the study visit
Interventions
- DIAGNOSTIC_TEST Cardiovascular Assessments
- DIAGNOSTIC_TEST Actigraphy
- DIAGNOSTIC_TEST Laboratory assessments
- DIAGNOSTIC_TEST Emotional/Behavioral Assessments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2022-05-31 |
What the finished NCT03934398 record still lists
NCT03934398 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Cardiovascular Assessments is the first listed.
NCT03934398 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03934398 about?
NCT03934398 is a clinical study titled "Be-HealthY: Behavioral Risk Factors for Poor Vascular Health in Youth". The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure. The investigators will also investigate for predictors of vascular function and determine if pr...
What is the current status of trial NCT03934398?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2019-04-10. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03934398?
The interventions under investigation include: Cardiovascular Assessments (DIAGNOSTIC_TEST), Actigraphy (DIAGNOSTIC_TEST), Laboratory assessments (DIAGNOSTIC_TEST), Emotional/Behavioral Assessments (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03934398?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI